Red Light Holland Announces Filament Health's Largest-Ever Manufacturing Run of PEX010, the Standardized and Patented Natural Psilocybin Drug Candidate Trusted Across 80+ Studies Globally, Now Offering the Widest Standardized Dosing Range, from 0.5 mg to 25 mg
Red Light Holland announced that its subsidiary Filament Health has commenced the largest manufacturing run in its history for PEX010, a standardized natural psilocybin drug candidate. To support this production increase and meet researcher demand, the company is introducing a new 0.5 mg microdosing strength, expanding its standardized range to 0.5 mg, 1 mg, 5 mg, and 25 mg.
Key figures
- Drug Name
- PEX010
- Studies count
- 80+
- Issued patents
- 76
- Patent families
- 13
- Total dose range
- 0.5 mg to 25 mg
- New dose strength
- 0.5 mg
- Shelf life months
- 36
- Existing dose strengths
- ["1 mg","5 mg","25 mg"]
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.